Australia's largest stock trading and investment forum Australia's #1 stock forum

IVZ invictus energy ltd

2.04%

5.0¢

Phone conversation with Scott - Jan 12th 2023., page-148

First 148 Last

Share
Profile

Follow
Roch2077

10,189 Posts.

1987

18/01/24

13:03

Post #: 71942819
Share

Originally posted by theforcewithin: ↑

Wouldn't he be astronomically stupid going ahead with a flow test if the data he had doesnt support that it would flow?

It would destroy his reputation and ostensibly the company to undertake such a fruitless endeavour. He has unequivocally stated in the past without hesitation saying it will flow.

Again, I'm far from an expert, but going ahead with a flow test and all his comments from the past support we should get good flow unless he is lying through his teeth and wasting the the company, shareholders and his own time and money with a flow test.

Expand

he sold and needs the re entry before news flow next week. Still a multi billion dollar asset and huge news flow coming within the next 1-2 weeks

sold on a CR just plain stupid

Last edited by Roch2077: 18/01/24

IVZ Price at posting: 11.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

First 148 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 5.0¢		Change 0.001(2.04%)		Mkt cap ! $80.17M

Open	High	Low	Value	Volume
5.0¢	5.2¢	4.8¢	$228.7K	4.596M

Buyers (Bids)

No.	Vol.	Price($)
1	290000	4.9¢

Sellers (Offers)

Price($)	Vol.	No.
5.0¢	119195	3

View Market Depth

No.	Vol.	Price($)
1	290000	0.049
4	686333	0.047
7	865281	0.046
5	573334	0.045
1	222222	0.043

Price($)	Vol.	No.
0.050	119195	3
0.051	560000	3
0.052	338003	2
0.053	544105	3
0.054	529496	5

Last trade - 16.10pm 27/06/2025 (20 minute delay)

IVZ (ASX) Chart

Phone conversation with Scott - Jan 12th 2023., page-148

Australia’s gas crisis is here – and dying coal plants aren’t helping

Boss extends June win streak with boosted Alta Mesa extraction rates

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Phone conversation with Scott - Jan 12th 2023., page-148

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

Boss extends June win streak with boosted Alta Mesa extraction rates

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

'Not possible' to port renewable gas: ACCC takes AGN to court

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News